Patents by Inventor Eugene Tu

Eugene Tu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240035082
    Abstract: The present disclosure provides compositions, methods and systems for sequencing a template nucleic acid using a polymerase based, nucleic acid binding reaction involving examination of the interaction between a polymerase and template nucleic acid in the presence of one or more unlabeled nucleotides. The methods rely, in part, on identifying a base of a template nucleic acid during nucleic acid synthesis by controlling the sequencing reaction conditions. Template nucleic acid bases may be identified during an examination step followed by an optional incorporation step.
    Type: Application
    Filed: October 11, 2022
    Publication date: February 1, 2024
    Applicant: Pacific Biosciences of California, Inc.
    Inventors: Kandaswamy VIJAYAN, Eugene TU, Mark A. BERNARD
  • Patent number: 11826130
    Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: November 28, 2023
    Assignee: VERISKIN, INC.
    Inventors: Mirianas Chachisvilis, Carl Frederick Edman, Eugene Tu
  • Patent number: 11499185
    Abstract: The present disclosure provides compositions, methods and systems for sequencing a template nucleic acid using a polymerase based, nucleic acid binding reaction involving examination of the interaction between a polymerase and template nucleic acid in the presence of one or more unlabeled nucleotides. The methods rely, in part, on identifying a base of a template nucleic acid during nucleic acid synthesis by controlling the sequencing reaction conditions. Template nucleic acid bases may be identified during an examination step followed by an optional incorporation step.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: November 15, 2022
    Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Inventors: Kandaswamy Vijayan, Eugene Tu, Mark A. Bernard
  • Publication number: 20220297123
    Abstract: A fluid processing device comprises multiple separate fluid channels and multiple processing stations configured to perform identical and simultaneous process steps on multiple fluid samples in the fluid channels. An embodiment of the fluid processing device is contained in a compact, low-cost, sealed consumable in which each processing station includes at least a reagent input well and a process chamber associated with each fluid channel. A reagent pack is associated with at least one processing station and includes at least one reagent chamber associated with each reagent input well. A barb actuator rod is associated with the processing station and includes a barb associated with each reagent chamber. Each barb actuator rod is movable between a first position in which each barb punctures the reagent chamber(s) associated with the barb and a second position in which each barb of the barb actuator rod does not contact the associated reagent chamber(s).
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: Lost Arrow Bio
    Inventors: Christopher KILCOIN, Eugene TU
  • Publication number: 20220298553
    Abstract: Method of identifying a cognate nucleotide (i.e., the “next correct nucleotide”) for a primed template nucleic acid molecule. In some embodiments, an ordered or random array of primed target nucleic acids characterized by different cognate nucleotides can be evaluated using a single imaging step to identify different cognate nucleotides for a collection of different primed template nucleic acid molecules. An optional incorporation step can follow the identifying step. A polymerase different from the ones used in the binding and examination steps can be used to incorporate a nucleotide, such as a reversible terminator nucleotide, preliminary to identification of the next cognate nucleotide.
    Type: Application
    Filed: December 29, 2021
    Publication date: September 22, 2022
    Applicant: Omniome, Inc.
    Inventors: Corey M. DAMBACHER, Devon CAYER, Richard LECOULTRE, Joseph ROKICKI, Kerry WILSON, Eugene TU, Kandaswamy VIJAYAN
  • Publication number: 20220162690
    Abstract: Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.
    Type: Application
    Filed: October 6, 2021
    Publication date: May 26, 2022
    Inventors: Kandaswamy VIJAYAN, Corey M. DAMBACHER, Eugene TU, Mark A. BERNARD, Joseph ROKICKI, Kerry WILSON
  • Patent number: 11326206
    Abstract: The present disclosure provides compositions, methods and systems for quantifying target sequences and identifying target sequence variants.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: May 10, 2022
    Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
    Inventors: Yi Zhang, Steven Brentano, Eugene Tu, Kandaswamy Vijayan
  • Patent number: 11248254
    Abstract: Method of identifying a cognate nucleotide (i.e., the “next correct nucleotide”) for a primed template nucleic acid molecule. In some embodiments, an ordered or random array of primed target nucleic acids characterized by different cognate nucleotides can be evaluated using a single imaging step to identify different cognate nucleotides for a collection of different primed template nucleic acid molecules. An optional incorporation step can follow the identifying step. A polymerase different from the ones used in the binding and examination steps can be used to incorporate a nucleotide, such as a reversible terminator nucleotide, preliminary to identification of the next cognate nucleotide.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: February 15, 2022
    Assignee: OMNIOME, INC.
    Inventors: Corey M. Dambacher, Devon Cayer, Richard LeCoultre, Joseph Rokicki, Kerry Wilson, Eugene Tu, Kandaswamy Vijayan
  • Publication number: 20220039674
    Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.
    Type: Application
    Filed: July 19, 2021
    Publication date: February 10, 2022
    Inventors: Mirianas CHACHISVILIS, Carl Frederick EDMAN, Eugene TU
  • Patent number: 11180749
    Abstract: A method for separating a target allele from a mixture of nucleic acids by (a) providing a mixture of nucleic acids in fluidic contact with a stabilized ternary complex that is attached to a solid support, wherein the stabilized ternary complex includes a polymerase, primed nucleic acid template, and next correct nucleotide, wherein the template has a target allele, wherein the next correct nucleotide is a cognate nucleotide for the target allele, and wherein the stabilized ternary complex is attached to the solid support via a linkage between the polymerase and the solid support or via a linkage between the next correct nucleotide and the solid support; and (b) separating the solid support from the mixture of nucleic acids, thereby separating the target allele from the mixture of nucleic acids.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: November 23, 2021
    Assignee: OMNIOME, INC.
    Inventors: Corey M. Dambacher, Eugene Tu
  • Patent number: 11168364
    Abstract: Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: November 9, 2021
    Assignee: OMNIOME, INC.
    Inventors: Kandaswamy Vijayan, Corey M. Dambacher, Eugene Tu, Mark A. Bernard, Joseph Rokicki, Kerry Wilson
  • Patent number: 11089969
    Abstract: A method and a device for diagnostic of skin cancer and other mammalian skin tissue pathologies are described. The method relies on determination of pathological changes in tissue vascularization and capillary blood flow. The device uses photonic emitters and detectors to characterize temporal and spatial changes in blood flow in response to external perturbation such as external mechanical force or temperature change.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: August 17, 2021
    Assignee: VERISKIN, INC.
    Inventors: Mirianas Chachisvilis, Carl Frederick Edman, Eugene Tu
  • Publication number: 20200002762
    Abstract: Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Inventors: Kandaswamy VIJAYAN, Corey M. DAMBACHER, Eugene TU, Mark A. BERNARD, Joseph ROKICKI, Kerry WILSON
  • Publication number: 20190359975
    Abstract: A method for separating a target allele from a mixture of nucleic acids by (a) providing a mixture of nucleic acids in fluidic contact with a stabilized ternary complex that is attached to a solid support, wherein the stabilized ternary complex includes a polymerase, primed nucleic acid template, and next correct nucleotide, wherein the template has a target allele, wherein the next correct nucleotide is a cognate nucleotide for the target allele, and wherein the stabilized ternary complex is attached to the solid support via a linkage between the polymerase and the solid support or via a linkage between the next correct nucleotide and the solid support; and (b) separating the solid support from the mixture of nucleic acids, thereby separating the target allele from the mixture of nucleic acids.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Applicant: Omniome, Inc.
    Inventors: Corey M. Dambacher, Eugene Tu
  • Patent number: 10443098
    Abstract: Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: October 15, 2019
    Assignee: OMNIOME, INC.
    Inventors: Kandaswamy Vijayan, Corey M. Dambacher, Eugene Tu, Mark A. Bernard, Joseph Rokicki, Kerry Wilson
  • Patent number: 10415029
    Abstract: A method for separating a target allele from a mixture of nucleic acids by (a) providing a mixture of nucleic acids in fluidic contact with a stabilized ternary complex that is attached to a solid support, wherein the stabilized ternary complex includes a polymerase, primed nucleic acid template, and next correct nucleotide, wherein the template has a target allele, wherein the next correct nucleotide is a cognate nucleotide for the target allele, and wherein the stabilized ternary complex is attached to the solid support via a linkage between the polymerase and the solid support or via a linkage between the next correct nucleotide and the solid support; and (b) separating the solid support from the mixture of nucleic acids, thereby separating the target allele from the mixture of nucleic acids.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: September 17, 2019
    Assignee: OMNIOME, INC.
    Inventors: Corey M. Dambacher, Eugene Tu
  • Publication number: 20190119742
    Abstract: The present disclosure provides compositions, methods and systems for quantifying target sequences and identifying target sequence variants.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 25, 2019
    Applicant: OMNIOME, INC.
    Inventors: Yi ZHANG, Steven BRENTANO, Eugene TU, Kandaswamy VIJAYAN
  • Patent number: 10253352
    Abstract: Provided herein are methods for analyzing a signature sequence in a nucleic acid sample by rapid sequencing of a target nucleic acid region. The method examines the target nucleic acid directly and minimizes the number of examination steps needed to determine a signature that is characteristic of a genetic feature of the nucleic acid sample.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: April 9, 2019
    Assignee: OMNIOME, INC.
    Inventors: Michael Nguyen, Eugene Tu
  • Patent number: 10246744
    Abstract: Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: April 2, 2019
    Assignee: OMNIOME, INC.
    Inventors: Kandaswamy Vijayan, Corey M. Dambacher, Eugene Tu, Mark A. Bernard, Joseph Rokicki, Kerry Wilson
  • Publication number: 20190032124
    Abstract: The present disclosure provides compositions, methods and systems for sequencing a template nucleic acid using a polymerase based, nucleic acid binding reaction involving examination of the interaction between a polymerase and template nucleic acid in the presence of one or more unlabeled nucleotides. The methods rely, in part, on identifying a base of a template nucleic acid during nucleic acid synthesis by controlling the sequencing reaction conditions. Template nucleic acid bases may be identified during an examination step followed by an optional incorporation step.
    Type: Application
    Filed: July 26, 2018
    Publication date: January 31, 2019
    Applicant: OMNIOME, INC.
    Inventors: Kandaswamy VIJAYAN, Eugene TU, Mark A. BERNARD